The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter cohort study of sunitinib (SU) versus imatinib (IM) dose escalation as second-line therapy in patients with gastrointestinal stromal tumors (GISTs) after disease progression of 400 mg/d IM.
 
Xinhua Zhang
No Relationships to Disclose
 
Xing Liu
No Relationships to Disclose
 
Xiao Jun Wu
No Relationships to Disclose
 
Zhizhong Pan
No Relationships to Disclose
 
Hui-shan Lu
No Relationships to Disclose
 
Yulong He
No Relationships to Disclose